Late thrombectomy for ischaemic stroke

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)213-215
Number of pages3
JournalThe Lancet
Issue number10321
Early online date11 Nov 2021
Publication statusPublished - 15 Jan 2022

Bibliographical note

Funding Information:
DD reports funding from the Dutch Heart Foundation, Brain Foundation Netherlands, The Netherlands Organisation for Health Research and Development, and Health Holland Top Sector Life Sciences and Health; and unrestricted grants from Penumbra, Stryker, Medtronic, Thrombolytic Science, and Cerenovus for research in acute stroke, all paid to his institution. He was co-principal investigator of the MR CLEAN trial, evaluating endovascular treatment, and is now co-research leader of the CONTRAST consortium, which facilitates the MR CLEAN LATE trial, a trial of thrombectomy for patients presenting between 6 h and 24 h from onset or time last seen well. BR reports funding from The Netherlands Organisation for Health Research and Development, paid to his institution. He is chair of the Dutch national guideline committee for acute ischaemic stroke and intracerebral haemorrhage. He leads the PRESTO studies on prehospital triage of stroke patients.

Cite this